Aditxt, Inc. (ADTX) Fair Value 2026

ADTX · Biotechnology ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.2 /10

32 fundamental signals · 1 models active

Value Trap Risk

WARN (41/100)

Quick Summary — As of 2026-07-15, Aditxt, Inc. (ADTX) trades at $0.00. QOC: 4.2/10. Value Trap Risk: 41/100 (WARN). 1/13 models active.

Key Facts

Ticker
ADTX
Price
$0.00
Quality Score
4.2/10
Value Trap Risk
41/100
Models Active
1/13
Last Updated
Strength: Regime Cross-Sectional suggests +212.5% upside with 17% confidence
Risk: Value Trap score of 41 suggests caution despite apparent undervaluation

Valuation Matrix

1 Intrinsic Value Models vs. Current Price ($0.00)

Core Models (Unlocked)
Model Fair Value Upside
Regime Cross-Sectional
Low Conviction
 $0.01 +212.5%

All Models Active

All 1 models are displayed above.

What Is Aditxt, Inc. (ADTX) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Aditxt, Inc. is potentially undervalued at its current price of $0.00. Based on our 13-model framework, Aditxt, Inc.'s intrinsic value is estimated at a composite fair value of $0.01 — representing +212.5% implied upside — with 1 out of 1 active models confirming this thesis.

What Do the Models Say About ADTX?

1 of 13 models are currently active for ADTX. All 1 active models suggest the stock trades below fair value. See which stocks rank higher →

How Does ADTX Rank in Biotechnology?

Among 76 Biotechnology stocks, ADTX ranks #60 by Quality of Company score. CirclFi's QOC score of 4.2/10 evaluates 32 fundamental signals. A score of 4.2 reflects mixed fundamentals.

See all Most Undervalued Biotechnology Stocks →

As a biotechnology enterprise, Aditxt, Inc. operates in a sector where pipeline depth and stage distribution is a critical driver of valuation. Investors evaluating ADTX should weigh these sector-specific dynamics alongside our model-derived fair values.

Is ADTX a Value Trap?

CirclFi's Value Trap algorithm assigns ADTX a score of 41/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for Aditxt, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Aditxt, Inc.'s fundamental quality profile registers 4.2/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ADTX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across ADTX's 1 active models, average confidence is 17%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Aditxt, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Biotechnology Stocks Should You Also Analyze?

8 related Biotechnology stocks with 13-model coverage

ADMAADMA Biologics IncQOC 10.0AUPHAurinia Pharmaceuticals IncQOC 9.5ACADACADIA Pharmaceuticals Inc.QOC 9.4ALNYAlnylam Pharmaceuticals, Inc.QOC 8.3ACRSAclaris Therapeutics, Inc.QOC 7.4ABCLAbCellera Biologics Inc.QOC 7.1ARCTArcturus Therapeutics Holdings QOC 7.0ARVNArvinas, Inc.QOC 6.9

Read investment analysis: ADMA · AUPH · ACAD · ALNY · ACRS

See all Biotechnology stocks ranked →

Frequently Asked Questions About Aditxt, Inc.

What is Aditxt, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Aditxt, Inc. (ADTX) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value. The Quality of Company score is 4.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ADTX overvalued or undervalued right now?

At $0.00, 1 of 1 active models suggest ADTX may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Aditxt, Inc.'s business model in Biotechnology.

What does a Quality of Company score of 4.2 mean for ADTX?

Aditxt, Inc.'s QOC of 4.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on ADTX?

CirclFi analyzes ADTX with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is ADTX a value trap in 2026?

Aditxt, Inc.'s Value Trap score is 41/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Aditxt, Inc. (ADTX) a Quality of Company score of 4.2/10 across 32 fundamental signals as of 2026-07-15.” Source: circlfi.com/stock/ADTX/ · Methodology